Analyst Research: Pfizer Inc (PFE)

PFE on New York Consolidated

29.84USD
30 Oct 2014
Price Change (% chg)

$0.35 (+1.19%)
Prev Close
$29.49
Open
$29.39
Day's High
$29.98
Day's Low
$29.39
Volume
21,097,190
Avg. Vol
24,798,842
52-wk High
$32.96
52-wk Low
$27.51

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
PowderMed, Ltd. 28 Oct 2014 GlobalData 9 125.00
Trading Report for (PFE). A detailed report, including free correlated market analysis, and updates. 27 Oct 2014 Stock Traders Daily 12 20.00
"The Economy Matters" Report for PFE: the economy's impact on PFE's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 27 Oct 2014 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for PFE 26 Oct 2014 ValuEngine, Inc. 11 25.00
PFE: Due Diligence Review: Forensic Earnings and Valuation 26 Oct 2014 New Constructs, LLC 9 25.00
Wright Investors Service Comprehensive Report for Pfizer Inc. 26 Oct 2014 Wright Reports 57 75.00
Pfizer, Inc 25 Oct 2014 S&P Capital IQ – STARS Reports 11 127.00
Our Economy without Stimulus; forward observations. 24 Oct 2014 Stock Traders Daily 102 20.00
PFIZER INC (PFE) - REPORT FOR ACTIVE TRADERS 24 Oct 2014 Pechala's Reports 1 25.00
PFIZER INC (PFE) 12-months forecast 24 Oct 2014 Pechala's Reports 1 15.00
 
Name Age Since Current Position

Ian Read

60 2011 Chairman of the Board, Chief Executive Officer

Frank D'Amelio

56 2010 Chief Financial Officer, Executive Vice President - Business Operations

Albert Bourla

52 2014 Group President - Vaccines, Oncology and Consumer Healthcare Business

Mikael Dolsten

55 2010 President - Worldwide Research and Development

Geno Germano

53 2014 Group President - Global Innovative Pharma Business
Search Stocks